16-89722813-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001113525.2(ZNF276):c.488G>A(p.Gly163Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000086 in 1,604,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001113525.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF276 | NM_001113525.2 | c.488G>A | p.Gly163Asp | missense_variant | 2/11 | ENST00000443381.7 | NP_001106997.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF276 | ENST00000443381.7 | c.488G>A | p.Gly163Asp | missense_variant | 2/11 | 1 | NM_001113525.2 | ENSP00000415836 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000421 AC: 64AN: 152196Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000905 AC: 22AN: 242964Hom.: 0 AF XY: 0.0000831 AC XY: 11AN XY: 132386
GnomAD4 exome AF: 0.0000510 AC: 74AN: 1451754Hom.: 0 Cov.: 31 AF XY: 0.0000388 AC XY: 28AN XY: 722522
GnomAD4 genome AF: 0.000420 AC: 64AN: 152314Hom.: 0 Cov.: 34 AF XY: 0.000443 AC XY: 33AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 02, 2024 | The c.488G>A (p.G163D) alteration is located in exon 2 (coding exon 2) of the ZNF276 gene. This alteration results from a G to A substitution at nucleotide position 488, causing the glycine (G) at amino acid position 163 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at